Physician profile
Brianna Freestone
NPI 1588150411
$2,396.74
in general payments reported to CMS, 2019-2025
33 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $792 · 2022: $865 · 2023: $456 · 2024: $148 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.96 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $237.73 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $203.50 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $173.11 | 2021 | |
| Harmony Biosciences LLC | $117.87 | 2023-2024 | Wakix |
| Glaxosmithkline, LLC. | $117.01 | 2023-2024 | Trelegy Ellipta, Nucala |
| Jazz Pharmaceuticals INC. | $116.93 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $114.48 | 2022-2025 | Dupixent |
| Amarin Pharma, INC. | $110.53 | 2021 | |
| Alnylam Pharmaceuticals INC. | $103.89 | 2021-2022 | |
| Amgen INC. | $96.42 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $91.16 | 2021-2022 | |
| Csl Behring | $90.02 | 2023-2024 | Hizentra |
| Esperion Therapeutics, INC. | $87.20 | 2021-2022 | |
| Novo Nordisk INC | $84.85 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.23 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $60.13 | 2022-2023 | Cuvitru |
| Kaleo, INC. | $57.32 | 2022-2023 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $56.66 | 2021-2024 | Airsupra |
| Kowa Pharmaceuticals America, INC. | $47.00 | 2021-2022 | |
| Axsome Therapeutics, INC. | $42.27 | 2022-2023 | Sunosi |
| Merck Sharp & Dohme LLC | $40.20 | 2021-2023 | |
| Arbor Pharmaceuticals, INC. | $39.90 | 2021 | |
| Genzyme Corporation | $31.19 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.48 | 2022 | |
| Alk-Abello, INC | $25.00 | 2022 | |
| Tactile Systems Technology INC | $23.44 | 2022 | |
| Abbott Laboratories | $23.19 | 2025 | Cardiomems |
| Aerin Medical INC. | $21.69 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.27 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $17.00 | 2022 | |
| Hikma Pharmaceuticals USA | $16.22 | 2023 | Ryaltris |
| Optinose US, INC. | $16.20 | 2024 | |
| Medtronic, INC. | $14.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brianna Freestone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.